Profile change history

What changed for Teriparatide?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Teriparatide identity.

160Total events
157Record additions
3Version changes
24Cited source years

Before and after

Preserved version changes

Profile updated

Teriparatide profile

We moved this profile to the current DailyMed label (SPL version 10, published September 21, 2026), which adds a separate warning about allergic reactions, and added the October 23, 2026 Drugs@FDA approval of a further generic teriparatide application. The previous version, citing label version 9, remains available.

PeptideScanner change date
November 15, 2026
Evidence lane
Profile

Cited source records

Before
dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a, fda-drugs-nda211939-2019-10-04-4790820cc8d4, fda-drugs-anda211097-2023-11-16-2855aa79a2e2, fda-drugs-nda218771-2024-06-04-4293d16697eb
After
dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v10, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a, fda-drugs-nda211939-2019-10-04-4790820cc8d4, fda-drugs-anda211097-2023-11-16-2855aa79a2e2, fda-drugs-nda218771-2024-06-04-4293d16697eb, fda-drugs-anda214412-2026-10-23-57b5e048e2bf

Named organizations

Before
U.S. National Library of Medicine [sources: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9]; U.S. Food and Drug Administration [sources: fda-drugs-nda021318-2002-11-26-2f4c2df07e0a]
After
U.S. National Library of Medicine [sources: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v10]; U.S. Food and Drug Administration [sources: fda-drugs-nda021318-2002-11-26-2f4c2df07e0a]

Claim citations

Before
name: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9; aliases: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a; category: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9; status: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a, fda-drugs-nda211939-2019-10-04-4790820cc8d4, fda-drugs-anda211097-2023-11-16-2855aa79a2e2, fda-drugs-nda218771-2024-06-04-4293d16697eb; summary: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a; evidenceNote: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9
After
name: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v10; aliases: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v10, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a; category: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v10; status: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v10, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a, fda-drugs-nda211939-2019-10-04-4790820cc8d4, fda-drugs-anda211097-2023-11-16-2855aa79a2e2, fda-drugs-nda218771-2024-06-04-4293d16697eb, fda-drugs-anda214412-2026-10-23-57b5e048e2bf; summary: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v10, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a; evidenceNote: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v10
Profile status changed

Teriparatide profile

We added a plain-language reader guide with cited answers, re-checked the generic teriparatide label, and added Drugs@FDA approval records for teriparatide products.

PeptideScanner change date
November 14, 2026
Evidence lane
Profile

Status

Before
U.S. label record
After
FDA-approved as Forteo and other teriparatide products

Profile summary

Before
A parathyroid hormone analogue. This profile cites a U.S. label record.
After
A parathyroid hormone analogue first approved by FDA as Forteo in 2002 for osteoporosis at high risk of fracture.

Evidence note

Before
The cited DailyMed label identifies Teriparatide and contains the product's official indications and warnings. This profile links to the label without restating it as medical guidance.
After
A large randomized, placebo-controlled trial described in the label found fewer new spine fractures than placebo. The label states that teriparatide caused osteosarcoma in rats; an increased risk has not been observed in human observational studies.

Related names

Before
None recorded
After
Forteo

Cited source records

Before
dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9
After
dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a, fda-drugs-nda211939-2019-10-04-4790820cc8d4, fda-drugs-anda211097-2023-11-16-2855aa79a2e2, fda-drugs-nda218771-2024-06-04-4293d16697eb

Named organizations

Before
U.S. National Library of Medicine [sources: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9]
After
U.S. National Library of Medicine [sources: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9]; U.S. Food and Drug Administration [sources: fda-drugs-nda021318-2002-11-26-2f4c2df07e0a]

Claim citations

Before
name: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9; aliases: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9; category: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9; status: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9; summary: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9; evidenceNote: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9
After
name: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9; aliases: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a; category: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9; status: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a, fda-drugs-nda211939-2019-10-04-4790820cc8d4, fda-drugs-anda211097-2023-11-16-2855aa79a2e2, fda-drugs-nda218771-2024-06-04-4293d16697eb; summary: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9, fda-drugs-nda021318-2002-11-26-2f4c2df07e0a; evidenceNote: dailymed-teriparatide-d77d40db-7f38-88eb-fd5d-4282f0642028-v9
Profile updated

Teriparatide profile

We rewrote the profile summary to describe the cited public record more directly. The cited sources and status did not change.

PeptideScanner change date
July 27, 2026
Evidence lane
Profile

Profile summary

Before
A parathyroid hormone analogue represented in current U.S. drug-label records.
After
A parathyroid hormone analogue. This profile cites a U.S. label record.

Collection chronology

Evidence added to PeptideScanner

Browse all 157 connected records →

Showing the latest 100 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 15, 2026.

Record added

Teriparatide DailyMed SPL version 10

DailyMed lists Structured Product Labeling version 10 for the reviewed Teriparatide label family with a published date of 2026-09-21. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
November 15, 2026
Cited source date
September 21, 2026
Evidence lane
Regulatory
Record added

Medication-related osteonecrosis of the external auditory canal and treatment with teriparatide.

PubMed lists PMID 42751062 in JCEM case reports as Case Reports, Journal Article, with publication-date metadata of 2026-09-16 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 14, 2026
Cited source date
September 18, 2026
Evidence lane
Literature metadata
Record added

Dendritic Mesoporous Silica-Modified Decellularized Bone Matrix Scaffold for Sustained Teriparatide Delivery in Bone Defect Repair: Characterization, Drug Release, and In Vitro Biological Performance.

PubMed lists PMID 42797243 in Pharmaceutics as Journal Article, with publication-date metadata of 2026-08-26 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 14, 2026
Cited source date
September 29, 2026
Evidence lane
Literature metadata
Record added

Conservative Treatment with Adjunctive Use of Teriparatide for Periprosthetic Humeral Fractures after Reverse Total Shoulder Arthroplasty: A Report of 6 Cases.

PubMed lists PMID 42876896 in Clinics in orthopedic surgery as Journal Article, Case Reports, with publication-date metadata of 2026-09-16 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 14, 2026
Cited source date
October 19, 2026
Evidence lane
Literature metadata
Record added

Bone-targeting engineered exosomes delivering teriparatide mRNA for the treatment of osteoporosis.

PubMed lists PMID 42926909 in Regenerative therapy as Journal Article, with publication-date metadata of 2026-10-16 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 14, 2026
Cited source date
October 26, 2026
Evidence lane
Literature metadata
Record added

Perioperative teriparatide use in osteopenic and osteoporotic patients undergoing multi- and long-segment posterior spinal fusion.

PubMed lists PMID 42995581 in BMC musculoskeletal disorders as Journal Article, with publication-date metadata of 2026-08-11 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 14, 2026
Cited source date
November 9, 2026
Evidence lane
Literature metadata
Record added

Development of Long-Acting Teriparatide Analogues through Iterative Peptide Scanning and Site-Specific Modification by Serine/Threonine Ligation.

PubMed lists PMID 43018567 in Journal of medicinal chemistry as Journal Article, with publication-date metadata of 2026-11-12 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 14, 2026
Cited source date
November 12, 2026
Evidence lane
Literature metadata
Record added

ClinicalTrials.gov record NCT02025179

PeptideScanner retained ClinicalTrials.gov record NCT02025179 at 2026-07-30T19:13:03.751Z. Its registry update date was 2023-05-10, and PeptideScanner's reviewed identity mapping was teriparatide.

PeptideScanner change date
September 9, 2026
Cited source date
May 10, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04750460

PeptideScanner retained ClinicalTrials.gov record NCT04750460 at 2026-07-30T19:32:59.860Z. Its registry update date was 2022-11-10, and PeptideScanner's reviewed identity mapping was teriparatide.

PeptideScanner change date
September 9, 2026
Cited source date
November 10, 2022
Evidence lane
Clinical trials
Record added

Early callus formation in human hip fracture treated with internal fixation and teriparatide.

PubMed lists PMID 18843769 in The Journal of rheumatology as Case Reports, Letter, with publication-date metadata of 2008-10 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
September 9, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Teriparatide DailyMed SPL version 2

DailyMed lists Structured Product Labeling version 2 for the reviewed Teriparatide label family with a published date of 2023-11-20. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
November 20, 2023
Evidence lane
Regulatory
Record added

Teriparatide DailyMed SPL version 3

DailyMed lists Structured Product Labeling version 3 for the reviewed Teriparatide label family with a published date of 2023-12-13. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
December 13, 2023
Evidence lane
Regulatory
Record added

Teriparatide DailyMed SPL version 4

DailyMed lists Structured Product Labeling version 4 for the reviewed Teriparatide label family with a published date of 2024-01-31. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
January 31, 2024
Evidence lane
Regulatory
Record added

Teriparatide DailyMed SPL version 5

DailyMed lists Structured Product Labeling version 5 for the reviewed Teriparatide label family with a published date of 2024-07-04. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
July 4, 2024
Evidence lane
Regulatory
Record added

Teriparatide DailyMed SPL version 6

DailyMed lists Structured Product Labeling version 6 for the reviewed Teriparatide label family with a published date of 2024-12-30. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
December 30, 2024
Evidence lane
Regulatory
Record added

Teriparatide DailyMed SPL version 7

DailyMed lists Structured Product Labeling version 7 for the reviewed Teriparatide label family with a published date of 2025-05-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
May 12, 2025
Evidence lane
Regulatory
Record added

Teriparatide DailyMed SPL version 8

DailyMed lists Structured Product Labeling version 8 for the reviewed Teriparatide label family with a published date of 2025-07-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
July 16, 2025
Evidence lane
Regulatory
Record added

Teriparatide DailyMed SPL version 9

DailyMed lists Structured Product Labeling version 9 for the reviewed Teriparatide label family with a published date of 2026-06-30. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
June 30, 2026
Evidence lane
Regulatory
Record added

Federal Register notice 01-14410

The Federal Register published notice 01-14410, attributed to FDA and its parent HHS department, on 2001-06-08. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committe; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Pramlintide and Teriparatide.

PeptideScanner change date
August 21, 2026
Cited source date
June 8, 2001
Evidence lane
Regulatory
Record added

Federal Register notice 2017-21202

The Federal Register published notice 2017-21202, attributed to FDA and its parent HHS department, on 2017-10-03. Its official title is “Abbreviated New Drug Applications for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of Recombinant Deoxyribonucleic Acid Origin; Draft Guidance for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide and Teriparatide.

PeptideScanner change date
August 21, 2026
Cited source date
October 3, 2017
Evidence lane
Regulatory
Record added

Federal Register notice 2024-18997

The Federal Register published notice 2024-18997, attributed to FDA and its parent HHS department, on 2024-08-23. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Teriparatide.

PeptideScanner change date
August 21, 2026
Cited source date
August 23, 2024
Evidence lane
Regulatory
Record added

Federal Register notice 2025-22131

The Federal Register published notice 2025-22131, attributed to FDA and its parent HHS department, on 2025-12-05. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide, Semaglutide, Teriparatide, Tirzepatide and Vosoritide.

PeptideScanner change date
August 21, 2026
Cited source date
December 5, 2025
Evidence lane
Regulatory
Record added

Federal Register notice 2026-15285

The Federal Register published notice 2026-15285, attributed to FDA and its parent HHS department, on 2026-07-29. Its official title is “Product-Specific Guidances; Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide, Semaglutide, Teriparatide, Tirzepatide and Vosoritide.

PeptideScanner change date
August 21, 2026
Cited source date
July 29, 2026
Evidence lane
Regulatory
Record added

Federal Register notice 99-24595

The Federal Register published notice 99-24595, attributed to FDA and its parent HHS department, on 1999-09-22. Its official title is “Wallace Laboratories et al.; Withdrawal of Approval of 18 New Drug Applications and 44 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Teriparatide.

PeptideScanner change date
August 21, 2026
Cited source date
September 22, 1999
Evidence lane
Regulatory
Record added

Teriparatide use during an economic crisis: baseline data from the Greek cohort of the Extended Forsteo Observational Study (ExFOS).

PubMed lists PMID 26044820 in BMC musculoskeletal disorders as Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-06-05 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 16, 2026
Cited source date
May 18, 2026
Evidence lane
Literature metadata
Record added

ClinicalTrials.gov record NCT04026256

PeptideScanner retained ClinicalTrials.gov record NCT04026256 at 2026-07-30T19:09:38.366Z. Its registry update date was 2023-08-02, and PeptideScanner's reviewed identity mapping was teriparatide.

PeptideScanner change date
August 14, 2026
Cited source date
August 2, 2023
Evidence lane
Clinical trials
Record added

Actual versus predicted first-year utilization patterns of teriparatide in patients with employer-sponsored health insurance.

PubMed lists PMID 18021497 in Current medical research and opinion as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-12 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 14, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Teriparatide and orthopedic surgery.

PubMed lists PMID 18182888 in Aging clinical and experimental research as Journal Article, with publication-date metadata of 2007-08 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 14, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use".

PubMed lists PMID 31408164 in The Journal of clinical endocrinology and metabolism as Comment, Letter, with publication-date metadata of 2019-12-01 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 14, 2026
Cited source date
August 13, 2026
Evidence lane
Literature metadata
Record added

Targeted drug repurposing in medication-related osteonecrosis of the jaw: a review of teriparatide and pentoxifylline/α-tocopherol protocols.

PubMed lists PMID 41852535 in Frontiers in medicine as Journal Article, Review, with publication-date metadata of 2026-03-03 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 14, 2026
Cited source date
August 13, 2026
Evidence lane
Literature metadata
Record added

Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB.

PubMed lists PMID 41987916 in JIMD reports as Journal Article, with publication-date metadata of 2026-04-13 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 14, 2026
Cited source date
August 13, 2026
Evidence lane
Literature metadata
Record added

Comparing Teriparatide and Bisphosphonates for Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis of RCTs.

PubMed lists PMID 42022682 in Health science reports as Journal Article, Review, with publication-date metadata of 2026-03-13 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 14, 2026
Cited source date
August 13, 2026
Evidence lane
Literature metadata
Record added

Acute use of teriparatide and palopegteriparatide in the management of hungry bone syndrome following parathyroidectomy.

PubMed lists PMID 42058698 in JCEM case reports as Case Reports, Journal Article, with publication-date metadata of 2026-04-28 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 14, 2026
Cited source date
August 13, 2026
Evidence lane
Literature metadata
Record added

A Comparison Between Bisphosphonates and Teriparatide in the Treatment of Postmenopausal Osteoporosis: A Systematic Review.

PubMed lists PMID 42083710 in Cureus as Journal Article, Review, with publication-date metadata of 2026-04-03 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 14, 2026
Cited source date
August 13, 2026
Evidence lane
Literature metadata
Record added

ClinicalTrials.gov record NCT00000400

PeptideScanner retained ClinicalTrials.gov record NCT00000400 at 2026-07-30T21:55:56.630Z. Its registry update date was 2013-12-09, and PeptideScanner's reviewed identity mapping was teriparatide.

PeptideScanner change date
August 13, 2026
Cited source date
December 9, 2013
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00035256

PeptideScanner retained ClinicalTrials.gov record NCT00035256 at 2026-07-30T22:39:13.109Z. Its registry update date was 2007-05-15, and PeptideScanner's reviewed identity mapping was teriparatide.

PeptideScanner change date
August 13, 2026
Cited source date
May 15, 2007
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00046137

PeptideScanner retained ClinicalTrials.gov record NCT00046137 at 2026-07-30T22:49:18.183Z. Its registry update date was 2006-07-20, and PeptideScanner's reviewed identity mapping was teriparatide.

PeptideScanner change date
August 13, 2026
Cited source date
July 20, 2006
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00079924

PeptideScanner retained ClinicalTrials.gov record NCT00079924 at 2026-07-30T22:39:13.107Z. Its registry update date was 2007-05-25, and PeptideScanner's reviewed identity mapping was teriparatide.

PeptideScanner change date
August 13, 2026
Cited source date
May 25, 2007
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00191321

PeptideScanner retained ClinicalTrials.gov record NCT00191321 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-01-26, and PeptideScanner's reviewed identity mapping was teriparatide.

PeptideScanner change date
August 13, 2026
Cited source date
January 26, 2007
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00191893

PeptideScanner retained ClinicalTrials.gov record NCT00191893 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-01-26, and PeptideScanner's reviewed identity mapping was teriparatide.

PeptideScanner change date
August 13, 2026
Cited source date
January 26, 2007
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06164795

PeptideScanner retained ClinicalTrials.gov record NCT06164795 at 2026-08-10T18:10:03.919Z. Its registry update date was 2026-07-22, and PeptideScanner's reviewed identity mapping was teriparatide.

PeptideScanner change date
August 13, 2026
Cited source date
July 22, 2026
Evidence lane
Clinical trials
Record added

Teriparatide (forteo) for osteoporsis.

PubMed lists PMID 12571538 in The Medical letter on drugs and therapeutics as Clinical Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2003-02-03 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Treating osteoporosis with teriparatide: many unknowns?

PubMed lists PMID 14610756 in Issues in emerging health technologies as Comparative Study, Journal Article, with publication-date metadata of 2003-11 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Teriparatide (rhPTH 1-34) for the treatment of osteoporosis.

PubMed lists PMID 14627183 in International journal of clinical practice as Journal Article, Review, with publication-date metadata of 2003-10 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

[Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].

PubMed lists PMID 14685711 in Zeitschrift fur Rheumatologie as Comparative Study, English Abstract, Journal Article, Review, with publication-date metadata of 2003-12 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Teriparatide for severe osteoporosis.

PubMed lists PMID 14742769 in The Annals of pharmacotherapy as Journal Article, Review, with publication-date metadata of 2003-12-30 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Teriparatide (Forteo) for osteoporosis.

PubMed lists PMID 15117021 in American family physician as Journal Article, with publication-date metadata of 2004-04-15 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.

PubMed lists PMID 15228497 in Basic & clinical pharmacology & toxicology as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2004-06 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

[Teriparatide (human recombinant 1-34 parathyroid hormone)--a new treatment regimen for severe osteoporosis].

PubMed lists PMID 15347166 in Ugeskrift for laeger as Journal Article, Review, with publication-date metadata of 2004-08-02 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Teriparatide for postmenopausal osteoporosis.

PubMed lists PMID 15587764 in Drug and therapeutics bulletin as Journal Article, Review, with publication-date metadata of 2004-12 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Teriparatide: new preparation. Osteoporosis: less well evaluated than alendronic acid.

PubMed lists PMID 15747448 in Prescrire international as Comparative Study, Journal Article, with publication-date metadata of 2005-02 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Initial experience with teriparatide in the United States.

PubMed lists PMID 16684431 in Current medical research and opinion as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2006-04 (month precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
November 21, 2013
Evidence lane
Literature metadata
Record added

Bioequivalence of Recombinant Human Teriparatide Injection in Healthy Adult Female Subjects in the Fasting State.

PubMed lists PMID 38923284 in Clinical pharmacology in drug development as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-06-24 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
July 1, 2026
Evidence lane
Literature metadata
Record added

Can Intermittent Teriparatide Facilitate Supraphysiological-Rate Distraction Osteogenesis? A Feasibility Study in the Rabbit Tibial Lengthening Model.

PubMed lists PMID 40657227 in Indian journal of orthopaedics as Journal Article, with publication-date metadata of 2025-05-27 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
May 28, 2026
Evidence lane
Literature metadata
Record added

Bonegraft Using Octacalcium Phosphate Collagen Composite with Teriparatide and Polylactic Acid Cage.

PubMed lists PMID 41311271 in Tissue engineering. Part A as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-02-16 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
June 10, 2026
Evidence lane
Literature metadata
Record added

Persistence of romosozumab vs. teriparatide in Japanese older adults aged ≥ 75 years with osteoporosis: a population-based cohort study.

PubMed lists PMID 41400755 in Archives of osteoporosis as Journal Article, Comparative Study, with publication-date metadata of 2025-12-16 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
July 13, 2026
Evidence lane
Literature metadata
Record added

Development of 1 month core-shell microspheres combination formulation containing teriparatide for osteoporosis treatment.

PubMed lists PMID 41950644 in Biomaterials as Journal Article, with publication-date metadata of 2026-04-05 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
July 14, 2026
Evidence lane
Literature metadata
Record added

Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: A Randomized Clinical Trial.

PubMed lists PMID 42133304 in JAMA as Journal Article, Randomized Controlled Trial, Multicenter Study, with publication-date metadata of 2026-07-14 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
July 15, 2026
Evidence lane
Literature metadata
Record added

Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: Research Summary.

PubMed lists PMID 42133336 in JAMA as Journal Article, with publication-date metadata of 2026-07-14 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
July 14, 2026
Evidence lane
Literature metadata
Record added

Transient teriparatide for postoperative hypocalcaemia with hungry bone features.

PubMed lists PMID 42592840 in European journal of endocrinology as Journal Article, with publication-date metadata of 2026-08-13 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
August 13, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 18623910

PeptideScanner retained PubMed bibliographic metadata for PMID 18623910 at 2026-07-30T22:38:13.927Z. PubMed recorded a metadata revision date of 2008-07-14 and an Entrez history date of 2008-07-16. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 14, 2008
Evidence lane
Literature metadata
Record added

PubMed record PMID 22840755

PeptideScanner retained PubMed bibliographic metadata for PMID 22840755 at 2026-07-30T21:57:01.388Z. PubMed recorded a metadata revision date of 2013-02-01 and an Entrez history date of 2012-07-31. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
February 1, 2013
Evidence lane
Literature metadata
Record added

PubMed record PMID 22986396

PeptideScanner retained PubMed bibliographic metadata for PMID 22986396 at 2026-07-30T22:15:26.556Z. PubMed recorded a metadata revision date of 2012-09-18 and an Entrez history date of 2012-09-19. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
September 18, 2012
Evidence lane
Literature metadata
Record added

PubMed record PMID 23897194

PeptideScanner retained PubMed bibliographic metadata for PMID 23897194 at 2026-07-30T21:57:02.018Z. PubMed recorded a metadata revision date of 2013-07-30 and an Entrez history date of 2013-07-31. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 30, 2013
Evidence lane
Literature metadata
Record added

PubMed record PMID 23982227

PeptideScanner retained PubMed bibliographic metadata for PMID 23982227 at 2026-07-30T21:57:02.020Z. PubMed recorded a metadata revision date of 2013-09-16 and an Entrez history date of 2013-08-29. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
September 16, 2013
Evidence lane
Literature metadata
Record added

PubMed record PMID 24026625

PeptideScanner retained PubMed bibliographic metadata for PMID 24026625 at 2026-07-30T21:57:02.022Z. PubMed recorded a metadata revision date of 2013-09-26 and an Entrez history date of 2013-09-13. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
September 26, 2013
Evidence lane
Literature metadata
Record added

PubMed record PMID 24076523

PeptideScanner retained PubMed bibliographic metadata for PMID 24076523 at 2026-07-30T21:57:02.024Z. PubMed recorded a metadata revision date of 2013-10-04 and an Entrez history date of 2013-10-01. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
October 4, 2013
Evidence lane
Literature metadata
Record added

PubMed record PMID 40978515

PeptideScanner retained PubMed bibliographic metadata for PMID 40978515 at 2026-08-10T10:49:06.968Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2025-09-22. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
August 2, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41686215

PeptideScanner retained PubMed bibliographic metadata for PMID 41686215 at 2026-08-10T18:13:40.663Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-02-13. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 26, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41999058

PeptideScanner retained PubMed bibliographic metadata for PMID 41999058 at 2026-08-10T10:49:08.848Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-04-18. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 30, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42294947

PeptideScanner retained PubMed bibliographic metadata for PMID 42294947 at 2026-08-10T18:13:52.269Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 26, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42355862

PeptideScanner retained PubMed bibliographic metadata for PMID 42355862 at 2026-08-10T18:13:53.757Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-26. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 26, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42355866

PeptideScanner retained PubMed bibliographic metadata for PMID 42355866 at 2026-08-10T18:13:53.757Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-26. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 26, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42398904

PeptideScanner retained PubMed bibliographic metadata for PMID 42398904 at 2026-08-10T18:13:53.834Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-03. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 29, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42513596

PeptideScanner retained PubMed bibliographic metadata for PMID 42513596 at 2026-08-10T10:49:12.877Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 30, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42516799

PeptideScanner retained PubMed bibliographic metadata for PMID 42516799 at 2026-08-10T18:13:56.766Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 29, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42521191

PeptideScanner retained PubMed bibliographic metadata for PMID 42521191 at 2026-08-10T18:13:56.780Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 28, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 18334980

PeptideScanner retained PubMed bibliographic metadata for PMID 18334980 at 2026-07-30T22:38:13.898Z. PubMed recorded a metadata revision date of 2008-04-28 and an Entrez history date of 2008-03-13. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 11, 2026
Cited source date
April 28, 2008
Evidence lane
Literature metadata
Record added

PubMed record PMID 18477986

PeptideScanner retained PubMed bibliographic metadata for PMID 18477986 at 2026-07-30T22:38:13.910Z. PubMed recorded a metadata revision date of 2008-06-23 and an Entrez history date of 2008-05-15. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 11, 2026
Cited source date
June 23, 2008
Evidence lane
Literature metadata
Record added

PubMed record PMID 41272927

PeptideScanner retained PubMed bibliographic metadata for PMID 41272927 at 2026-08-10T10:49:06.999Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2025-11-22. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 11, 2026
Cited source date
August 3, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41748193

PeptideScanner retained PubMed bibliographic metadata for PMID 41748193 at 2026-08-10T10:49:08.774Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-02-26. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 11, 2026
Cited source date
August 3, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41904726

PeptideScanner retained PubMed bibliographic metadata for PMID 41904726 at 2026-08-10T10:49:08.825Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-03-29. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 11, 2026
Cited source date
August 6, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42532234

PeptideScanner retained PubMed bibliographic metadata for PMID 42532234 at 2026-08-10T10:49:12.924Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-07-30. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 11, 2026
Cited source date
August 3, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41949681

PeptideScanner retained PubMed bibliographic metadata for PMID 41949681 at 2026-08-10T10:49:08.835Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-04-08. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 10, 2026
Cited source date
August 6, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42501079

PeptideScanner retained PubMed bibliographic metadata for PMID 42501079 at 2026-08-10T10:49:10.788Z. PubMed recorded a metadata revision date of 2026-08-07 and an Entrez history date of 2026-07-25. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 10, 2026
Cited source date
August 7, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42568899

PeptideScanner retained PubMed bibliographic metadata for PMID 42568899 at 2026-08-10T10:49:13.608Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2026-08-08. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 10, 2026
Cited source date
August 8, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42570209

PeptideScanner retained PubMed bibliographic metadata for PMID 42570209 at 2026-08-10T10:49:13.625Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2026-08-08. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 10, 2026
Cited source date
August 8, 2026
Evidence lane
Literature metadata
Record added

ClinicalTrials.gov record NCT00005006

PeptideScanner retained ClinicalTrials.gov record NCT00005006 at 2026-07-30T21:41:27.764Z. Its registry update date was 2015-08-19, and PeptideScanner's reviewed identity mapping was teriparatide.

PeptideScanner change date
August 9, 2026
Cited source date
August 19, 2015
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00051558

PeptideScanner retained ClinicalTrials.gov record NCT00051558 at 2026-07-30T22:26:45.005Z. Its registry update date was 2009-03-12, and PeptideScanner's reviewed identity mapping was teriparatide.

PeptideScanner change date
August 9, 2026
Cited source date
March 12, 2009
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00190944

PeptideScanner retained ClinicalTrials.gov record NCT00190944 at 2026-07-30T22:39:13.107Z. Its registry update date was 2007-10-12, and PeptideScanner's reviewed identity mapping was teriparatide.

PeptideScanner change date
August 9, 2026
Cited source date
October 12, 2007
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00191867

PeptideScanner retained ClinicalTrials.gov record NCT00191867 at 2026-07-30T22:39:13.109Z. Its registry update date was 2007-11-06, and PeptideScanner's reviewed identity mapping was teriparatide.

PeptideScanner change date
August 9, 2026
Cited source date
November 6, 2007
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00239629

PeptideScanner retained ClinicalTrials.gov record NCT00239629 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-06-12, and PeptideScanner's reviewed identity mapping was teriparatide.

PeptideScanner change date
August 9, 2026
Cited source date
June 12, 2007
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00259298

PeptideScanner retained ClinicalTrials.gov record NCT00259298 at 2026-07-30T22:25:23.113Z. Its registry update date was 2010-08-11, and PeptideScanner's reviewed identity mapping was teriparatide.

PeptideScanner change date
August 9, 2026
Cited source date
August 11, 2010
Evidence lane
Clinical trials